Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Free Base Ruxolitinib 941678-49-5,JAK Inhibitor Ruxolitinib 941678-49-5,Myelofibrosis Treatment Ruxolitinib 941678-49-5
Conbott Pharmtech Co.,Ltd. Free Base Ruxolitinib 941678-49-5,JAK Inhibitor Ruxolitinib 941678-49-5,Myelofibrosis Treatment Ruxolitinib 941678-49-5
Home > Products > Inhibitors > JAK Inhibitors > Ruxolitinib (INCB018424) JAK Inhibitor CAS 941678-49-5 
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Ruxolitinib (INCB018424) JAK Inhibitor CAS 941678-49-5 

Share to:  
    Payment Type: L/C,T/T
    Min. Order: 1 Gram
    Delivery Time: 10 Days

Basic Info

Model No.: 941678-49-5 

Additional Info

Packaging: As required

Productivity: Customized

Brand: Conbottpharm

Transportation: Ocean,Air

Place of Origin: China

Supply Ability: Commercial

Certificate: Documents Support

Product Description

Ruxolitinib with CAS number of 941678-49-5 and 1092939-17-7 is short for (R)-3-(4-(7H-Pyrrolo [2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. It is a off-white solid with purity of ≥99% by HPLC. Molecular Formula is C17H18N6 and Molecular Weight is 306.371. It belongs to APIs. Ruxolitinib 941678-49-5 is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. It can stable for at least 2 years after receipt when stored at -20°C. This product plays key role in our company and has sold on many markets. The price and quality are competitive.

Thera. Category: JAK Inhibitor

Cas No.:941678-49-5

Synonym : INCB018424 (Ruxolitinib);Jakafi,Ruxolitinib;(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;1H-Pyrazole-1-propanenitrile,.beta.-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-,(.beta.R)-;(3R)-3-(4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyriMidin-4-yl}-1H-pyrazol-1-yl)propanenitrile;INCB018424 (Ruxolitinib);Jakafi

941678-49-5

Molecular Formula: C17H18N6

Molecular Weight: 306.371

Purity: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Looking for ideal Free Base Ruxolitinib 941678-49-5 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the JAK Inhibitor Ruxolitinib 941678-49-5 are quality guaranteed. We are China Origin Factory of Myelofibrosis Treatment Ruxolitinib 941678-49-5. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > JAK Inhibitors

Product Images
  • Ruxolitinib (INCB018424) JAK Inhibitor CAS 941678-49-5 
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?